Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 10,733,419	$ 4,465,455
Accounts receivable, net	310,517	424,287
Inventories, net	678,906	439,533
Prepaid expenses and other	920,383	820,206
Total Current Assets	12,643,225	6,149,481
Restricted cash	75,000	75,000
Deferred offering costs		219,240
Equipment, net	109,880	154,972
Total Assets	12,828,105	6,598,693
Current Liabilities:
Convertible note payable, net of discount of $71,360 and $676,703 at June 30, 2020 and December 31, 2019, respectively	996,841	1,763,887
Accounts payable and accrued expenses	1,689,031	1,738,490
Derivative liabilities	888	378,239
Deferred revenue	1,495	2,913
Total Current Liabilities	2,688,255	3,883,529
Long-term debt, net of discount of $36,169 at December 31, 2019		888,961
Other long-term debt liabilities	77,892
Deferred revenue	8,700	1,495
Total Liabilities	2,774,847	4,773,985
Commitments and Contingencies
Stockholders’ Equity:
Common stock par value $0.0001 per share, 100,000,000 shares authorized; 3,223,876 and 574,524 shares issued as of June 30, 2020 and December 31, 2019, respectively; and 3,223,849 and 574,497 shares outstanding at June 30, 2020 and December 31, 2019, respectively	322	57
Additional paid-in capital	73,274,309	57,957,097
Accumulated deficit	(63,214,909)	(56,125,982)
Treasury stock, 27 shares at cost	(6,464)	(6,464)
Total Stockholders’ Equity	10,053,258	1,824,708
Total Liabilities and Stockholders’ Equity	$ 12,828,105	$ 6,598,693